BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33446808)

  • 1. Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation.
    Yoon M; Oh J; Chun KH; Lee CJ; Kang SM
    Sci Rep; 2021 Jan; 11(1):1426. PubMed ID: 33446808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.
    Gardiner BJ; Nierenberg NE; Chow JK; Ruthazer R; Kent DM; Snydman DR
    Clin Infect Dis; 2018 Oct; 67(9):1395-1402. PubMed ID: 29635432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute Lymphocyte Count as a Marker for Cytomegalovirus Infection After Heart Transplantation.
    Schoeberl AK; Zuckermann A; Kaider A; Aliabadi-Zuckermann A; Uyanik-Uenal K; Laufer G; Goekler J
    Transplantation; 2023 Mar; 107(3):748-752. PubMed ID: 36228318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Lymphopenia at 1 Month Posttransplant and Infectious Outcomes or Death in Heart Transplant Recipients.
    Perry WA; Paulus JK; Price LL; Snydman DR; Chow JK
    Clin Infect Dis; 2021 Dec; 73(11):e3797-e3803. PubMed ID: 33279963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients.
    Fries BC; Khaira D; Pepe MS; Torok-Storb B
    Exp Hematol; 1993 Sep; 21(10):1387-92. PubMed ID: 8395404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: effect of preemptive therapy.
    Mendez-Eirin E; Paniagua-Martín MJ; Marzoa-Rivas R; Barge-Caballero E; Grille-Cancela Z; Cañizares A; Naya-Leira C; Gargallo-Fernández P; Castro-Beiras A; Crespo-Leiro M
    Transplant Proc; 2012 Nov; 44(9):2660-2. PubMed ID: 23146486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.
    Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM;
    Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of cytomegalovirus in cardiac transplant recipients receiving induction immunosuppression with antithymocyte globulin.
    Jewani PK; Pouch SM; Kissling KT
    Clin Transplant; 2018 Nov; 32(11):e13420. PubMed ID: 30290013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a "Safe Corridor" after kidney transplantation?
    El Helou G; Lahr B; Razonable R
    Transpl Infect Dis; 2021 Apr; 23(2):e13489. PubMed ID: 33037728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.
    Fernández-Ruiz M; Silva JT; López-Medrano F; Allende LM; San Juan R; Cambra F; Justo I; Paz-Artal E; Jiménez C; Aguado JM
    Transpl Infect Dis; 2016 Aug; 18(4):552-65. PubMed ID: 27260953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretransplant lymphopenia is a novel prognostic factor in cytomegalovirus and noncytomegalovirus invasive infections after liver transplantation.
    Nierenberg NE; Poutsiaka DD; Chow JK; Cooper J; Price LL; Freeman RB; Rohrer R; Snydman DR
    Liver Transpl; 2014 Dec; 20(12):1497-507. PubMed ID: 25205044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of cytomegalovirus infection and subsequent allograft failure after pancreas transplantation.
    Yetmar ZA; Kudva YC; Seville MT; Bosch W; Huskey JL; Jarmi T; Kukla A; Dean PG; Razonable RR; Beam E
    Am J Transplant; 2024 Feb; 24(2):271-279. PubMed ID: 37839709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation.
    Nagai S; Yoshida A; Kohno K; Altshuler D; Nakamura M; Brown KA; Abouljoud MS; Moonka D
    Hepatology; 2014 Jan; 59(1):35-45. PubMed ID: 23728831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus prophylaxis in seropositive renal transplant recipients receiving thymoglobulin induction therapy: Outcome and risk factors for late CMV disease.
    Reusing JO; Feitosa EB; Agena F; Pierrotti LC; Azevedo LSF; Kotton CN; David-Neto E
    Transpl Infect Dis; 2018 Oct; 20(5):e12929. PubMed ID: 29809309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant persistent lymphopenia is a strong predictor of late survival in isolated intestine and multivisceral transplantation.
    Nagai S; Mangus RS; Anderson E; Ekser B; Kubal CA; Burch T; Fridell JA; Tector AJ
    Transpl Int; 2015 Oct; 28(10):1195-204. PubMed ID: 26095310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood cyclosporine concentrations and cytomegalovirus infection following heart transplantation.
    Best NG; Trull AK; Tan KK; Spiegelhalter DJ; Wreghitt TG; Wallwork J
    Transplantation; 1995 Oct; 60(7):689-94. PubMed ID: 7570978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation.
    Einsele H; Ehninger G; Steidle M; Fischer I; Bihler S; Gerneth F; Vallbracht A; Schmidt H; Waller HD; Müller CA
    Blood; 1993 Sep; 82(5):1672-8. PubMed ID: 8395913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-index as a novel index to evaluate both the intensity and duration of lymphopenia after allogeneic hematopoietic stem cell transplantation.
    Kimura SI; Wada H; Sakamoto K; Ashizawa M; Sato M; Terasako K; Nakasone H; Kikuchi M; Okuda S; Kako S; Yamazaki R; Oshima K; Tanaka Y; Tanihara A; Nishida J; Kanda Y
    Transpl Infect Dis; 2012 Aug; 14(4):364-73. PubMed ID: 22469427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of cytomegalovirus infection in non-transplant pediatric acute lymphoblastic leukemia patients during chemotherapy.
    Phasuk N; Keatkla J; Rattanasiri S; Techasaensiri C; Anurathapan U; Apiwattanakul N
    Medicine (Baltimore); 2019 Jan; 98(4):e14256. PubMed ID: 30681620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the immunosuppressive regimen on the incidence of cytomegalovirus infection in 378 heart transplant recipients: A single centre, prospective cohort study.
    Durante-Mangoni E; Andini R; Pinto D; Iossa D; Molaro R; Agrusta F; Casillo R; Grimaldi M; Utili R
    J Clin Virol; 2015 Jul; 68():37-42. PubMed ID: 26071333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.